Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00423046
Status:
COMPLETED
Last Update Posted:
2020-01-02
First Post:
2007-01-16
Brief Title:
Immunogenicity of GlaxoSmithKline Biologicals Human Papillomavirus HPV Vaccine 580299 Versus Mercks Gardasil in Healthy Females 18-45 Years of Age
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2008-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-16
First Submit QC Date:
January 16 2007
Study First Post Date:
2007-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-08-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-27
Last Update Post Date:
2020-01-02
Last Update Post Date Type:
ACTUAL